vs

Side-by-side financial comparison of Baird Medical Investment Holdings Ltd (BDMD) and Currenc Group Inc. (CURR). Click either name above to swap in a different company.

Currenc Group Inc. is the larger business by last-quarter revenue ($10.1M vs $8.0M, roughly 1.3× Baird Medical Investment Holdings Ltd). Currenc Group Inc. runs the higher net margin — -46.5% vs -142.7%, a 96.2% gap on every dollar of revenue. Currenc Group Inc. produced more free cash flow last quarter ($-1.7M vs $-3.2M).

Baird Medical Investment Holdings Ltd is a healthcare-focused investment holding company mainly operating in the Chinese market. It invests in and manages businesses covering in vitro diagnostic devices, medical consumables, and community healthcare services, serving clinical institutions and individual consumers.

BDMD vs CURR — Head-to-Head

Bigger by revenue
CURR
CURR
1.3× larger
CURR
$10.1M
$8.0M
BDMD
Higher net margin
CURR
CURR
96.2% more per $
CURR
-46.5%
-142.7%
BDMD
More free cash flow
CURR
CURR
$1.6M more FCF
CURR
$-1.7M
$-3.2M
BDMD

Income Statement — Q2 FY2025 vs Q1 FY2025

Metric
BDMD
BDMD
CURR
CURR
Revenue
$8.0M
$10.1M
Net Profit
$-11.4M
$-4.7M
Gross Margin
82.1%
31.8%
Operating Margin
-131.3%
-43.0%
Net Margin
-142.7%
-46.5%
Revenue YoY
-23.3%
Net Profit YoY
-54.0%
EPS (diluted)
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDMD
BDMD
CURR
CURR
Q2 25
$8.0M
Q1 25
$10.1M
Q3 24
$11.3M
Q1 24
$13.1M
Q3 23
$12.7M
Net Profit
BDMD
BDMD
CURR
CURR
Q2 25
$-11.4M
Q1 25
$-4.7M
Q3 24
$-5.0M
Q1 24
$-3.0M
Q3 23
$-3.8M
Gross Margin
BDMD
BDMD
CURR
CURR
Q2 25
82.1%
Q1 25
31.8%
Q3 24
27.8%
Q1 24
33.6%
Q3 23
32.5%
Operating Margin
BDMD
BDMD
CURR
CURR
Q2 25
-131.3%
Q1 25
-43.0%
Q3 24
-141.5%
Q1 24
-10.8%
Q3 23
-18.2%
Net Margin
BDMD
BDMD
CURR
CURR
Q2 25
-142.7%
Q1 25
-46.5%
Q3 24
-44.1%
Q1 24
-23.2%
Q3 23
-30.1%
EPS (diluted)
BDMD
BDMD
CURR
CURR
Q2 25
Q1 25
$-0.13
Q3 24
$-0.13
Q1 24
$-0.09
Q3 23
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDMD
BDMD
CURR
CURR
Cash + ST InvestmentsLiquidity on hand
$62.3M
Total DebtLower is stronger
$8.4M
$3.7M
Stockholders' EquityBook value
$35.6M
$-68.4M
Total Assets
$77.0M
$110.8M
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDMD
BDMD
CURR
CURR
Q2 25
Q1 25
$62.3M
Q3 24
$49.1M
Q1 24
Q3 23
Total Debt
BDMD
BDMD
CURR
CURR
Q2 25
$8.4M
Q1 25
$3.7M
Q3 24
$20.1M
Q1 24
Q3 23
Stockholders' Equity
BDMD
BDMD
CURR
CURR
Q2 25
$35.6M
Q1 25
$-68.4M
Q3 24
$-47.0M
Q1 24
$-10.9M
Q3 23
$-10.2M
Total Assets
BDMD
BDMD
CURR
CURR
Q2 25
$77.0M
Q1 25
$110.8M
Q3 24
$115.0M
Q1 24
$54.5M
Q3 23
$82.0M
Debt / Equity
BDMD
BDMD
CURR
CURR
Q2 25
0.24×
Q1 25
Q3 24
Q1 24
Q3 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDMD
BDMD
CURR
CURR
Operating Cash FlowLast quarter
$-3.2M
$-1.5M
Free Cash FlowOCF − Capex
$-3.2M
$-1.7M
FCF MarginFCF / Revenue
-40.7%
-16.5%
Capex IntensityCapex / Revenue
0.6%
1.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDMD
BDMD
CURR
CURR
Q2 25
$-3.2M
Q1 25
$-1.5M
Q3 24
$-11.3M
Q1 24
$-221.0K
Q3 23
$-10.5M
Free Cash Flow
BDMD
BDMD
CURR
CURR
Q2 25
$-3.2M
Q1 25
$-1.7M
Q3 24
Q1 24
$-233.0K
Q3 23
FCF Margin
BDMD
BDMD
CURR
CURR
Q2 25
-40.7%
Q1 25
-16.5%
Q3 24
Q1 24
-1.8%
Q3 23
Capex Intensity
BDMD
BDMD
CURR
CURR
Q2 25
0.6%
Q1 25
1.7%
Q3 24
Q1 24
0.1%
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BDMD
BDMD

Segment breakdown not available.

CURR
CURR

Sales Of Airtime$5.5M54%
Fiat Remittance Service$4.4M44%

Related Comparisons